Navigation Links
Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease

ORLANDO, Fla. and NUTLEY, N.J., April 12, 2007 /PRNewswire-FirstCall/ -- Data analyses from the largest initial registration clinical trial program ever undertaken in the renal anemia arena provide efficacy and safety information on the investigational anemia therapy MIRCERA(TM) for the treatment of renal anemia associated with chronic kidney disease (CKD) in patients on dialysis and not on dialysis. Three data analyses were presented at the National Kidney Foundation 2007 Spring Clinical Meetings in Orlando, Florida.

According to these analyses, MIRCERA with extended dosing up to once every four weeks: (1) corrected and maintained hemoglobin (Hb) levels in patients with CKD, on dialysis and not on dialysis; (2) maintained Hb levels in dialysis patients, regardless of congestive heart failure (CHF) status as shown in a post-hoc analysis; and (3) exhibited a safety profile that is consistent with that of commercially available erythropoiesis stimulating agents (ESAs) and typical of those associated with this patient population.

"The goal in treating renal anemia is to safely maintain target hemoglobin levels," said Steven Fishbane, MD, Associate Director of Nephrology, Associate Chairman of the Department of Medicine, and Director of End-Stage Renal Disease research at Winthrop University Hospital. "These data analyses clearly demonstrate that MIRCERA corrected low hemoglobin levels, and maintained target hemoglobin levels with the added convenience of up to once- monthly dosing."

About the Studies

Safety and Tolerability of C.E.R.A. In Patients With Chronic Kidney Disease: Pooled Data From Ten Phase II-III Trials

Pooled data from four Phase II and six Phase III studies evaluated the safety and tolerability of MIRCERA (intravenous (IV) and subcutaneous (SC)) in patients not previously treated with commercially available ESAs and those previously treated with commercially availa
'"/>




Page: 1 2 3 4

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
5. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
6. Prospective Model Outlined Potential Time and Cost Savings of Once-Monthly Anemia Treatment
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
11. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
Post Your Comments:
(Date:9/1/2015)... 1, 2015 - ... R egistry data presented at ESC ... on the evolution of manag ing AF ... -   The first-ever two-year outcomes from the Global ... 2015 expose that all-cause death was the most frequent major event in more ...
(Date:9/1/2015)... Norway , September 1, 2015 ... biopharmaceutical company, today announces that it has appointed ... as Non-Executive Directors to its Board of Directors, effective ... 30 years of experience in pharma and biotech and ... Genzyme, a Sanofi company. Previously her role was Vice ...
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and ... Sciences Policy Forum to state legislators. The new policy ... Diagnostics in Indianapolis and featured ... Ellspermann and State Sen. Brandt Hershman . ... new Learning & Development Center, which is under construction ...
Breaking Medicine Technology:Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9BerGenBio Appoints Non-Executive Directors 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3
... NEW YORK, Jan. 4, 2011 Reportlinker.com announces that a ... Cosmetic Surgery Products http://www.reportlinker.com/p060973/Cosmetic-Surgery-Products.html ... through 2014 Demand for products used in ... to $2.8 billion in 2014, when 16.1 million cosmetic procedures ...
... Jan. 3, 2011 Dynatronics Corporation (Nasdaq: ... of an agreement with Premier Purchasing Partners, L.P., the ... contracted supplier of physical therapy products and exercise equipment ... alternate market facilities.   Premier, Inc. is ...
Cached Medicine Technology:Reportlinker Adds Cosmetic Surgery Products 2Reportlinker Adds Cosmetic Surgery Products 3Dynatronics Named Contract Supplier to Premier, Inc. 2
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and resolves ... treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Jerry Segal Classic to benefit the patients ... Valley Country Club in Lafayette Hill, PA. Over the past 26 years, the Classic, ... programs and services designed to support patients and their families during their time at ...
(Date:9/1/2015)... San Francisco, Calif. (PRWEB) , ... September 01, ... ... services to corporations, law firms and government entities, announced today that it has ... as Senior Discovery Consultant. In this capacity, Sanderson will be responsible for ...
(Date:9/1/2015)... ... 2015 , ... Zecurion, a leading developer of data loss prevention solutions, announced ... DLP developed specifically for Mac OS. , In June 2015, the company successfully completed ... security professionals had participated. The beta test done by the developer community enabled Zecurion ...
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s ... relations through food and dining. , Recently named “the next big thing” in ... are known for telling the whole story behind food and reclaiming culinary traditions on ...
Breaking Medicine News(10 mins):Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4
... Jan. 3 Bedford Laboratories(TM), a,division of ... of,CAFCIT(R) (caffeine citrate) Injection and CAFCIT(R) (caffeine ... Bedford Laboratories is now the,reference listed drug ... short term treatment of apnea in premature ...
... help predict which children are at risk for malignancy, ... Dutch scientists have discovered that children who have ... limbs and curvature of the spine. , This suggests ... and the anomaly, raising hopes that genetic information may ...
... BUFFALO GROVE, Ill., Jan. 3 Alma Lasers ... a registration statement with,the U.S. Securities and Exchange ... of its ordinary shares., The initial public ... being offered by Alma Lasers and secondary shares ...
... It,s not just the money: New Center for Excellence poll ... pay ranks farther down list, WASHINGTON, Jan. 3 ... the top of Americans, list of,desirables in a job, while ... Princeton Survey Research Associates,for the Center for State and Local ...
... Former CFO of Cholestech Brings Strong Financial Expertise ... Promotions, HAYWARD, Calif., Jan. 3 Thermage, Inc.,(Nasdaq: ... in the aesthetic,industry, today announced the appointment of John ... the former CFO of Cholestech,Corporation, succeeds Laureen DeBuono, who ...
... live on surfaces for several days, experts say, , , THURSDAY, ... called the stomach flu, can be passed from one person ... computer keyboards and computer mice, U.S. health officials report. , ... most frequent cause of outbreaks of vomiting and diarrhea in ...
Cached Medicine News:Health News:Bedford Laboratories(TM) Announces the Acquisition of CAFCIT(R) (Caffeine Citrate) Injection CAFCIT(R) (Caffeine Citrate) Oral Solution 2Health News:Body Abnormalities, Childhood Cancer May Share Genes 2Health News:Body Abnormalities, Childhood Cancer May Share Genes 3Health News:Alma Lasers Announces Proposed Initial Public Offering 2Health News:Health Care and Security: What Americans Want from a Job 2Health News:Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer 2Health News:Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer 3Health News:Stomach Flu Spread By Contaminated Computer Keyboards 2Health News:Stomach Flu Spread By Contaminated Computer Keyboards 3
... 1000 Power Instrument System is a ... versatility and convenience with modular and ... without hand throttle, for use with ... pedal. Accepts all 1000 and 2000 ...
... The Brasseler USA™ 2002 Battery Charger is manufactured ... The 2002 Battery Charger can charge up to ... minutes. The 2002 Charger is designed to operate ... there is a malfunction in the operation of ...
... diamond shaped teeth set the blade on a straight ... are very sharp, and the cut starts true, dancing ... with minimal force due to the sharp, smooth ground, ... , ,The troughs between the teeth provide ...
The High Speed Drill handpiece is a well-balanced, high performance drill that provides high speed for,bone sculpting, along with power for difficult osteotomies. Must be used with the 6401-000 foot ...
Medicine Products: